Detailed Information on Publication Record
2016
Elevation of cardiac troponin T in patients with amyotrophic lateral sclerosis
MACH, Lukáš, Tomas KONECNY, Kateřina HELÁNOVÁ, Allan S. JAFFE, Eric J. SORENSON et. al.Basic information
Original name
Elevation of cardiac troponin T in patients with amyotrophic lateral sclerosis
Authors
MACH, Lukáš (203 Czech Republic, belonging to the institution), Tomas KONECNY (203 Czech Republic), Kateřina HELÁNOVÁ (203 Czech Republic, guarantor), Allan S. JAFFE (840 United States of America), Eric J. SORENSON (840 United States of America), Virend K. SOMERS (840 United States of America) and Guy S. REEDER (840 United States of America)
Edition
Acta Neurologica Belgica, Heidelberg, Springer Heidelberg, 2016, 0300-9009
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30201 Cardiac and Cardiovascular systems
Country of publisher
Germany
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 1.722
RIV identification code
RIV/00216224:14110/16:00089280
Organization unit
Faculty of Medicine
UT WoS
000387681300019
Keywords in English
Acute coronary syndrome; Neuromuscular disease; Amyotrophic lateral sclerosis; Troponin T
Tags
Tags
International impact, Reviewed
Změněno: 12/5/2017 12:32, Mgr. Michal Petr
Abstract
V originále
Limited evidence suggests that specificity of cardiac troponin T (cTnT), a highly sensitive biomarker of myocardial injury, is reduced in patients with skeletal myopathies. Whether amyotrophic lateral sclerosis (ALS) the most common motor neuron disease could be also associated with abnormal plasma or serum cTnT levels remains unclear. Our objective was to assess cTnT levels in patients with ALS without known cTnT elevating conditions. Among ALS patients seen at our institution until 2012 we identified those who had their cTnT measured. Patients who suffered from conditions known to elevate cTnT were excluded. A case–control analysis comparing cTnT levels of these ALS patients to matched non-ALS controls fulfilling the same inclusion criteria was performed. We included 40 ALS patients of whom 27 (68 %) patients had a positive cTnT. In the control group (n = 40), 2 (5 %) tested as cTnT positive. Among the ALS patients who underwent cTnT evaluation on more occasions (n = 7; median followup = 1.08 years), 2 (29 %) patients tested positive during the initial measurement while 6 (86 %) of them had positive cTnT at the subsequent evaluations. ALS patients with increased cTnT had been diagnosed with ALS significantly earlier than those without the elevation. Our findings raise the possibility that ALS may cause cTnT elevations. Further studies are needed to confirm these findings, clarify the pathophysiological mechanism, and establish the significance of cTnT elevations in patients with ALS.